Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$0.12 - $0.3 $3,790 - $9,475
-31,584 Reduced 44.26%
39,784 $5,000
Q4 2022

Feb 15, 2023

BUY
$0.15 - $0.63 $10,705 - $44,961
71,368 New
71,368 $12,000
Q1 2022

May 17, 2022

SELL
$3.54 - $8.3 $46,154 - $108,215
-13,038 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$7.69 - $19.66 $100,262 - $256,327
13,038 New
13,038 $104,000

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.